# JOENJA
> **NDA217759** · New Drug Application · Sponsor: PHARMING · Approved 2023-03-24
## Drug
- **FDA Application Number:** NDA217759
- **Application type:** New Drug Application
- **Brand name:** JOENJA
- **Generic name:** LENIOLISIB
- **Active ingredients:** LENIOLISIB PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARMING
- **Manufacturer:** Pharming Healthcare Inc.
- **First approval:** 2023-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217759)
---
*AI Analytics · CC0 1.0*